Free shipping on all orders over $ 500

Finerenone

Cat. No. M9957

All AbMole products are for research use only, cannot be used for human consumption.

Finerenone Structure
Synonym:

BAY94-8862

Size Price Availability Quantity
1mg USD 30  USD30 In stock
5mg USD 75  USD75 In stock
10mg USD 110  USD110 In stock
25mg USD 220  USD220 In stock
50mg USD 330  USD330 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Finerenone (BAY 94-8862) is a third generation selective, oral active, non-steroidal halocorticoid receptor (MR) antagonist (IC50=18 nM). Finerenone showed good selectivity (>500-fold) compared to glucocorticoid receptor (GR), androgen receptor (AR), and progesterone receptor (AR). Finerenone has potential applications in the study of heart and kidney diseases, such as type 2 diabetes and chronic kidney disease.

Protocol (for reference only)
Cell Experiment
Cell lines Human coronary artery smooth muscle cells
Preparation method Cells are incubated with aldosterone with or without finerenone for 24 hours after 24 hours of serum-starvation for the assessment of cell proliferation and apoptosis. Immediately prior to the addition of aldosterone, cells are preincubated with finerenone or vehicle for 30 minutes.
Concentrations 1 nM, 10 nM
Incubation time 24 h
Animal Experiment
Animal models Twelve-week-old MWF, aged-matched normoalbuminuric Wistar rats
Formulation in 10% EtOH, 40% PEG400, 50% water
Dosages 10 mg/kg/day
Administration p.o.
Chemical Information
Molecular Weight 378.43
Formula C21H22N4O3
CAS Number 1050477-31-0
Solubility (25°C) DMSO ≥ 90 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Licette C Y Liu, et al. Expert Opin Investig Drυgs. Finerenone : third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney disease

[2] Peter Kolkhof, et al. J Cardiovasc Pharmacol. Finerenone, a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury

Related Mineralocorticoid Receptor Products
Spironolactone

Spironolactone (SC9420) is an oral active aldosterone mineralocorticoid receptor antagonist with an IC50 value of 24 nM. Spironolactone is also an androgen receptor antagonist with an IC50 of 77 nM. Spironolactone promotes podocyte autophagy.

Potassium canrenoate

Canrenoate potassium is a predrug for the release of Canrenone and an effective antagonist of competitive salt ocorticoid receptor. As a diuretic, Canrenoate potassium is used in the study of hypertension.

Osilodrostat

Osilodrostat (LCI699) is a potent, orally active11β-hydroxylase (CYP11B1) inhibitor with an IC50 value of 35 nM. Osilodrostat is a potent, orally aldosterone synthase (CYP11B2) inhibitor with IC50 values of 0.7 nM and 160 nM for human aldosterone synthase and rat aldosterone synthase, respectively.

Canrenone

Canrenone is a mineralocorticoid receptor antagonist.

Esaxerenone (CS-3150)

Esaxerenone (CS-3150) is a highly potent and selective non-steroidal mineralocorticoid receptor antagonist.

  Catalog
Abmole Inhibitor Catalog




Keywords: Finerenone, BAY94-8862 supplier, Mineralocorticoid Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.